I am an independent science journalist, with around 13 years of biomedical research experience in molecular cell biology, stem cells and cancer research.
The usual science journalism restricts itself to repeating after the cues given by scientific elite and leading research institutions. What we mostly read in the science news, is the voice of power and money. The climate of fear is omnipresent in science: bad science is very rarely exposed in the open, fraud and ethics breach are routinely covered up, while accusations and criticisms are raised only behind closed doors and are often unfairly or even wrongfully assigned. There are many good and honest scientists out there, but they have no voice. My site is for them.
Therefore, one goal of my site is to give voice to such concerned scientists who would normally never dare to speak out their critique, for fear of their influential colleagues. Some of these voices are named, some names are confidential. You can be one of them, just contact me below.
My conference presentations are available for you to browse and re-use at Slideshare. Some of my seminars are available as videos on YouTube. My academic CV and original research publications are listed on ORCID. Finally, I am also a cartoonist, please visit my Facebook page Science Cartoons.
I welcome your opinions, suggestions and stories for my future journalistic investigations. Confidentiality guaranteed! Please leave a functional email address where I can reach you, if you want me to follow up on information you share.
Yours, Leonid Schneider
PS: those of my “special” readers, who aren’t interested in talking to me, but rather in engaging lawyers and German courts to stop my reporting, can save time searching for my residence address (Landungsanschrift): Taunusstr. 11, 63526 Erlensee, Germany
The new ERC President Mauro Ferrari used to closely collaborate with two very controversial cancer researchers at MD Anderson in Texas: Anil Sood and Gabriel Lopez-Beerestein. Will that experience affect ERC’s already wanting stance on research integrity?
Royal Society of Chemistry published a research paper which unashamedly peddled TCM, under the title: “Probing the Qi of traditional Chinese herbal medicines by the biological synthesis of nano-Au”. Both Editor-in-Chief and publisher executive saw no problem there because the paper passed peer review.
Sir Martin Evans, winner of Nobel prize 2007, founded in 2009 the stem cell start-up Celixir, together with a struck-off dentist Ajan Reginald. With the help of the British heart surgeon Stephen Westaby, they ran a very profitable clinical trial in Greece, which now moved into UK.
The 2008 Lancet paper of Paolo Macchiarini and Martin Birchall about the world first trachea transplant might end up retracted. Until recently, the journal’s editor Richard Horton used to ignore and suppress “non peer-reviewed” evidence, but due to combined pressure of activism, media and politics, things started to move.
In yet another investigation, UCL whitewashed Martin Birchall of all responsibilities. I publish here the confidential report and excerpts from a secret PhD thesis, which the UCL committee carefully avoided to read.
The trachea-transplanting company Videregen, based in Liverpool, got another £2 million grant from UK governmental agency Innovate UK, to advance their tracheal replacement technology.
Manipulated data in 17 papers from one cancer research lab in China gets flagged on PubPeer. It ends with the university hospital in Wuhan issuing a secret statement accusing the US pharma giant a Merck of a conspiracy to slander a Chinese Academy member, Dr Ding Ma.
The team around the paediatric oncologist Nabil Ahmed at Baylor College of Medicine in Houston, Texas, discovered a way to engineer T-leukocytes to bypass the blood-brain barrier at attack otherwise untreatable brain cancers. Their amazing technology to get this published in Nature was brazenly insolent data fakery.
Professor Ruben Plentz chose to focus his career on clinical medicine in Bremen, despite his tremendous academic achievements in cancer research. Was it because malicious critics harassed him with frivolous investigations and corrections, envious at all those peer-reviewed cancer cures the great doctor invented?
A decision was announced by the Swedish Prosecution Authority in Gothenburg on the Paolo Macchiarini case today. The issue are plastic trachea transplants the scandal surgeon performed at the hospital of the Karolinska Institutet (KI) in Stockholm, Sweden. The earlier decision by state prosecutor was changed in part and the preliminary investigation will be reopened
Paediatric surgeon Paolo De Coppi claims to grow all possible internal organs in his lab at UCL. Though his career started with his association with Macchiarini, and their regenerative medicine ideas sound strangely similar, De Coppi is celebrated as a modest genius poised to save lives of uncounted children, and the funding money flows.